Best Abstract Award




Best Abstract Award

PURPOSE:

AAPS selects the best abstracts from hundreds of submissions and highlights them during PharmSci 360 each year. The Best Abstract Awards bring attention to the most exciting research to be found in the posters, based on abstracts that are submitted and screened before the event.

IDEAL RECIPIENT:

An AAPS member who has submitted one of the top-rated abstracts for PharmSci 360.

Number Presented Annually: Top 10% of abstracts based on highest screener ratings for each of the following categories:

  • Graduate students
  • Postdoctoral candidates
  • Young academic scientists with fewer than 3 years in academia
  • Young industrial scientists with fewer than 3 years in industry
  • AAPS members who do not meet the criteria for one of the above categories

Presentation: PharmSci 360

Award: Signs or other visuals in the Solution Center (Exhibit Hall) directing attention to the winning posters.

Expectations for Recipient: Participation in PharmSci 360 poster program in year of receipt.

Nomination Type: Highest ranked abstracts as determined by screeners during AAPS’ blinded poster screening process that have been authored by qualified candidates are automatically forwarded for consideration.

Qualifications for Nomination:

  • Must be an AAPS member at time of abstract submission
  • Must be the single lead author of the abstract
  • Abstract must be ranked by screeners in the top 10% of abstracts for one of the following groups:
    • Graduate students
    • Postdoctoral candidates
    • Young academic scientists with fewer than 3 years in academia
    • Young industrial scientists with fewer than 3 years in industry
    • AAPS members who do not meet the criteria for one of the above categories

Nomination Process: AAPS will automatically identify candidates and verify their qualifications, then advance nominees to AAPS Awards Committee. Candidates do not complete an application form.

2025 PharmSci 360 Best Abstract Award Winners

See these and all the posters at PharmSci 360 in November

  • 3D Printed Ileum Targeted Tablet for the Treatment of IgA Nephropathy, Xiaoling Li, Triastek, Inc.
  • A Breakthrough Predictive Model for Rapid and Accurate Solubility Parameter Prediction of Lipids for Lipid-Based Drug Delivery Systems, Ryan Varghese Mathew, Saint Joseph's University
  • A Data-Efficient Approach to Design Stable Solid-State Lipid Nanoparticles for Microneedle Application, Khanh Tran, Massachusetts Institute of Technology
  • A Novel Approach to Preclinical Drug Development Using Digital Twins of Ex Vivo Human Lungs, Xuanzi Zhou, University Health Network
  • Achieving Sustained Supersaturation of Poorly Soluble Naringenin through Cocrystal Engineering, Sanika Jadhav, University of Iowa
  • Brain-Targeted ApoE2 Gene Delivery Across the Blood-Brain Barrier using Dual-functionalized Liposomal Nanoparticles for Alzheimer's Disease Therapy, Chinenye Muolokwu, North Dakota State University
  • Calcium-Enhanced Chromatography for the Purification of Polar Ammonium and Peptide Compounds, Travis Menard, Southwest Research Institute
  • Can Molecular Descriptors Drive Nanosuspension Innovation? Leveraging Machine Learning and AI to Predict the Particle Size, Vishvesh Raje, St. John's University
  • Comprehensive Design and Characterization of pH-Gradient-Loaded Donkey-Milk Exosomes for Oral Octreotide Delivery: A Bench-to-In Silico Roadmap, Sandeep Padakanti, Florida Agricultural and Mechanical University
  • Development and Verification of Novel Agarose Gel Based Dialysis Cassette System as an In Vitro Release Model for Long-Acting Injectable Formulations, Lakshmi Satwika Golagana, AbbVie Inc.
  • Development of a Cannabidiol Dry Powder Inhaler Using Sodium Stearate: Enhancement of Aerosol Performance and Stability, Hyeon-Seo Moon, Jeonbuk National University
  • Development of a Novel Fast Dissolvable Microneedle-Based Delivery System for the Next-Generation Influenza Nanovaccine, Emmanuel Adediran, Mercer University
  • Discovery of Mitochondria Targeted Non-apoptotic Cell Death Inducers against Resistant Triple-Negative Breast Cancer, Saloni Sood, University of Arkansas for Medical Sciences
  • Discovery of Pan-EphB Tyrosine Kinase Inhibitors to Reverse Metabolic Syndrome in Obese Mice, Syed Tareq, Texas Tech University Health Sciences Center
  • Engineered Nanobody-Bearing Exosomes Enable Precision Trop2 Knockdown in Resistant Breast Cancer, Mandip Singh, Florida Agricultural and Mechanical University
  • Engineering Tumor and HEK Cells to Produce Multi-Targeted Exosomes: A New Frontier in Targeted Checkpoint Therapy., Mounika Aare, Florida A &M University
  • Evaluating the Immunogenicity of Painless Microneedle Microparticulate Combination Vaccine for COVID-19 and Flu, Mahek Anil Gulani, Mercer University
  • Extracellular Vesicle Transcriptomic Analysis for Understanding Muscle Aging under the Influence of Microgravity, Samantha Ali, University of Florida
  • Growth and Differentiation Factor 5: A Therapeutic Path for Chondrogenic Progenitor Cell-Based Cartilage Regeneration to Prevent Post-Traumatic Osteoarthritis, Rui He, University of Iowa
  • GSH-Responsive Heparin-Artesunate/Chlorin e6 Nanomicelles for Dual Synergistic Ferroptosis Therapy in Triple-Negative Breast Cancer, Zi Hang Wei, FuJian Medical University
  • Identifying the Targets of Ocular Tissue-Targeting RNA Aptamers by Proteome Integral Solubility Alteration (PISA) Assay, Katariina Maekiniemi, University of Eastern Finland
  • Immunogenicity and Safety Assessment of Engineered mRNA Lipid Nanoparticles for Pulmonary Delivery, Arian Veyssi, University of Texas at Austin
  • In Situ Forming Implants: The Effect of Drug-Polymer-Solvent Interplay on Depot Behavior, Mckenzie Roy, University of Connecticut
  • Inhaled Delivery of Synergistic Alginate Lyase-Ceftazidime Combination to Eradicate Pulmonary <em>Pseudomonas aeruginosa</em> Biofilms, Sharon Shui Yee Leung, Chinese University of Hong Kong
  • Intratumoral Delivery of Lapatinib via pH-Responsive Liposomes Embedded in a Thermosensitive In Situ Hydrogel: A Potential Chemotherapeutic Modality for Breast Cancer, Junia Akhtar, National Institute of Pharmaceutical Education and Research
  • Kolliphor(® P407-CPBA Functionalized PLGA Nanoparticles for Co-Delivery of Sorafenib and Venetoclax: A Synergistic Strategy Targeting Ferroptosis and Apoptosis in Breast Cancer, Sanyog Jain, National Institute for Pharmaceutical Education and Research
  • Leveraging Carnitine-Functionalized Lipid Nanocarrier-Based Targeted Delivery of A1874 PROTAC for Glioblastoma, Himaxi Patel, St. John's University
  • Leveraging Protein as a Local Buffering Agent to Safeguard Probiotics in Alginate Encapsulates during Gastric Transit, Haixi Cui, University of Maryland Baltimore
  • Machine Learning Predicts Drug Release Profiles Based on Tablets’ Formulations, Chrystalla Protopapa, National and Kapodistrian University of Athens
  • Mitochondria-Targeted Delivery of Metabolic Modulators to Tumor-Associated Macrophages for Immunotherapy, Nishat Ara, Texas A&M University
  • Model-Informed Precision Dosing of Riluzole in Acute Spinal Cord Injury Using Pharmacokinetic, Pharmacodynamic, and Clinical Outcome Modeling, Junghwa Park, University of Houston
  • Monitoring of NOXConcentration on Fluidized Bed Dryer and Evaluation of Its Reduction Method, Satoshi Kodama, Powrex Corporation
  • NGS-Based Platform for Detecting Lentiviral Insertion Sites and Genomic Integration, Junyan Chen, Accurant Biotech
  • Overcoming Intracellular Delivery Challenges of Small- and Large-Molecule Through First-in-Class Macropinocytosis Activators, Veronica Piedra, University of Arkansas for Medical Sciences
  • Pharmacological Inhibition of Macrophage Activation by a Gut Microbiota Metabolite Indole-3 Acetic Acid, Sreelakshmi Menon, Mercer University
  • Predicting Drug Release from EVA-Based Long-Acting Implants: Mechanisms, Modeling, and Simulation of Drug Release, Ziyue Zhong, University of Texas at Austin
  • Programmable Delayed-Release Container System (PDRCS) for Chronopharmaceutical Drug Delivery: Application to Addison’s Disease, Ahmed Wadi, University of Mississippi
  • Respiratory and Genomic Effects Induced by Phosphine Gas Exposure: Insights from Mouse Model to Identify Therapeutic Targets, Esraa Mohamed, University of Iowa
  • Sandwiched Nanofiber Sheets and Hybrid Gel for Localized and Prolonged Management of Cervical Cancer, Anne Boyina Sravani, Yenepoya Technology Incubator, Yenepoya (Deemed To Be University)
  • Self-Micellizing Dry Powder Inhaler System for Cyclosporine A Using Sodium Stearate, Eun-Bo Shim, Jeonbuk National University
  • Synergistic Cannabichromene–Cannabidiol Co-Therapy Reprograms Signaling, Epigenetics, and Pharmacokinetics to treat Drug-Resistant Triple-Negative Breast Cancer, Mounika Aare, Florida A &M University
  • Tailored Sodium Alginate-Based Hydrogel System for Submucosal Lifting: A Breakthrough in Endoscopic Mucosal Resection and Submucosal Dissection, Iram Maqsood, University of Maryland Baltimore
  • Transdermal Administration of Rivastigmine Using Hydrogel-Forming Microneedles as a Potential Treatment for Alzheimer’s disease, Zhikang Li, Queen's University Belfast
  • Tumor-Targeting Polymeric Micelles for Nose-to-Brain Delivery of Near-Infrared Imaging Agents for Optical Image-Guided Brain Surgery, Kranthi Gattu, St. John's University
  • Ultraflexible Liposomes Enhance Topical Delivery of ADT-007 for Potential Melanoma Therapy, Shivani Amarbhai Dave, Massachusetts College of Pharmacy and Health Sciences
  • Unveiling PNAG Dynamics in Bacterial Biofilms through Microfluidics and Fluorescence Microscopy, Steven Hong, University of Maryland College Park
  • Urolithin A-Laden P2Ns-GA Enhances Anticancer Efficacy in Cisplatin-Resistant Ovarian Cancer and Mitigate Nephrotoxicity in a Murine Model, Abiodun Wahab, University of Alabama